Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
06/2004
06/10/2004US20040110208 Use of exonuclease for removal of nucleotides from nucleic acids which then pass from a reaction chamber through a microfluidic channel and enter a nanochannel packed with nanoparticle aggregates
06/10/2004CA2505266A1 2'-0-trisubstituted silyloxymethyl-ribonucleoside-derivative and method for preparing the same
06/09/2004EP1425022A1 Mutagenic nucleoside analogs for the treatment of viral disease
06/09/2004CN1503805A Salts of avermectins substituted in the 4''-position and having pesticidal properties
06/09/2004CN1502622A Diuridine tetraphosphate or salt crystal thereof, process for producing the same, and process for producing the compounds
06/09/2004CN1152881C New indolocarbazole alkaloids from marine actinomycete, its composition and use
06/08/2004US6747143 Methods for polymer synthesis
06/08/2004US6747142 Multiple methoxyoxalamido and succinimido precursors for nucleophilic addition
06/03/2004WO2004046368A1 Novel antibiotic muraminomicin
06/03/2004WO2004046331A2 2’-branched nucleosides and flaviviridae mutation
06/03/2004WO2004046159A1 Antiviral nucleoside derivatives
06/03/2004WO2004046147A1 Polynucleotide derivative and use thereof
06/03/2004WO2004046066A1 Method for deuteration or tritiation of heterocyclic ring
06/03/2004WO2004045545A2 Compositions and methods for the treatment of cancer, screening of putative anti-cancer compounds, and assessing cancer progression
06/03/2004WO2004045371A2 Methods for diagnosing the presence or stage of cancer
06/03/2004WO2003020739A3 Novel lna compositions and uses thereof
06/03/2004US20040106785 Inhibitors of RNA dependent RNA polymerase and uses thereof
06/03/2004CA2506129A1 2'-branched nucleosides and flaviviridae mutation
06/03/2004CA2506010A1 A method for deuteration of a heterocyclic ring
06/03/2004CA2505735A1 Methods for diagnosing the presence or stage of cancer
06/02/2004EP1424341A2 Production method for purine nucleotide derivative disodium crystals and alcohol removing method
06/02/2004CN1501941A Chemical compounds
06/02/2004CN1501940A Composition and method for inhibiting platelet aggregation
06/02/2004CN1501939A Crystal of pyrimidine nucleoside derivative
06/02/2004CN1500800A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (HBV)
06/02/2004CN1152042C Partial or full A agonists-N heterocyclic 5' thio substituted adenosine devivatives
06/02/2004CN1152041C C-pyrazoleA receptor agonists
06/02/2004CN1152040C Carbazole derivatives, preparing process thereof and pharmaceutical combination containing the same
06/02/2004CN1151794C Medicinal compositions for treating eye diseases
06/02/2004CN1151775C Method of treating dry eye disease with purinergic receptor agonists
06/01/2004US6743902 For use in antisense therapy for enhancing nuclease resistance and cellular uptake
06/01/2004US6743882 Functionalized silicon compound for use in the treatment of glass
06/01/2004US6743782 Acyl derivative of 2'-deoxyadenosine; treating or preventing radiation, mutagen and sunlight-induced cellular damage, improving wound healing and tissue repair, ameliorating the effects of aging; enhance bioavailability
05/2004
05/27/2004WO2004043402A2 Modified nucleosides as antiviral agents
05/27/2004US20040102461 Synergistic mixture with anticancer drugs
05/27/2004US20040102414 Methods and compositions for treating flaviviruses and pestiviruses
05/27/2004US20040102413 Method and reagent for the inhibition of telomerase enzyme
05/27/2004US20040101947 A cationic or nonionic surfactant having a hydrophobic-lipophilic balance value from about 11 to 16 and a cell membrane altering compound, used for extracting a protein or peptide from target cell
05/27/2004US20040101932 Compositions and methods for targeted enzymatic release of cell regulatory compounds
05/27/2004US20040101897 Production method for purine nucleotide derivative disodium crystals and alcohol removing method
05/27/2004US20040101892 Nucleic acid labeling compounds
05/27/2004US20040101535 Administering nucleoside, or prodrug thereof; viricides
05/26/2004EP1422225A1 Benzoisoselenazole derivatives with anti-inflammation, antivirus and anti-thrombosis activity and their use
05/26/2004EP1421213A2 Labeled nucleoside polyphosphates
05/26/2004EP1421094A1 4"-deoxy-4"-(s)-amino avermectin derivatives
05/26/2004EP1296996B1 Purine derivatives
05/26/2004CN1500094A Building blocks for solution phase synthesis of oligonucleotides
05/26/2004CN1151167C Purine derivatives
05/26/2004CN1151166C Crystal of diruidine tetraphosphate or salt thereof and method for preparing same, and method for producing said compound
05/26/2004CN1151127C Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
05/25/2004US6740644 Chemical compounds
05/21/2004WO2004042086A1 Gas jet process and apparatus for high-speed amplification of dna
05/21/2004WO2004042003A2 Cell lysis compositions, methods of use, apparatus, and kit
05/21/2004WO2004041837A1 Novel cytarabine monophosphate prodrugs
05/21/2004WO2004041834A2 Novel cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs
05/21/2004WO2004041828A1 Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer
05/21/2004WO2004041203A2 Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
05/21/2004CA2504129A1 Cell lysis compositions, methods of use, apparatus, and kit
05/20/2004US20040097722 Preparation of phosphorothioate oligomers
05/20/2004US20040097462 Methods and compositions for treating flaviviruses and pestiviruses
05/20/2004US20040097461 Methods and compositions for treating hepatitis C Virus
05/20/2004US20040097438 Fused-ring compounds and use thereof as drugs
05/20/2004US20040096947 Biosynthesis using enzyme; immobilized to activated polymer support
05/20/2004US20040096825 Kits for use in multiplexed assay of interaction between ligands/target antiligands
05/20/2004US20040096518 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
05/20/2004US20040096397 Sulfonated diarylrhodamine dyes
05/19/2004EP1420021A1 DNA Methyltransferase inhibitors
05/19/2004EP1419778A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
05/19/2004EP1419167A1 1-(2,5'-anhydro-lyxofuranosyl) thymines for the synthesis of radiomarked fluoro-3 deoxynucleotides
05/19/2004EP1419157A2 HETEROCYCLIC COMPOUND BASED ON N sp 6 /sp −SUBSTITUTED ADENINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE
05/19/2004EP1418949A2 Inhibitor of dna methylation
05/19/2004EP1200478A4 Method for assaying compounds affecting smooth muscle contractile state
05/19/2004DE60101056T2 Verfahren zur Herstellung von Ribavirin Process for the preparation of ribavirin
05/19/2004CN1498221A Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase
05/19/2004CN1496989A New [3,4-a: 3.4-c] carbazole compound, its preparation method and drug composition containing them
05/18/2004US6737236 Derivatizing oligonucleotides and proteins using cycloaddition reactions including diels-alder reaction or 1,3-dipolar cycloaddition reactions
05/13/2004WO2004040003A2 Nucleotide-binding protein-directed probes and methods of their synthesis and use
05/13/2004WO2004039824A1 Modified guanosines having flavouring activity
05/13/2004WO2004039469A2 Process of purifying phosphoramidites
05/13/2004WO2003072586B1 Methods of producing phosphitylated compounds
05/13/2004US20040092476 Anticancer agents; viricides
05/13/2004US20040091407 Novel process for preparing crystalline particles of a salt of a substance, particularly particles of therapeutically useful or carrier substances of a size suitable for inhalation therapy.
05/13/2004CA2502821A1 Process of purifying phosphoramidites
05/12/2004EP1418179A2 Compositions and methods for detecting and modulating rna activity and gene expression
05/12/2004EP1417967A1 Novel virus proliferation inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue
05/12/2004EP1416795A1 Compositions and methods for treatment of mitochondrial diseases
05/12/2004EP0815114B1 Nucleic acid synthesis using photoremovable protecting groups
05/12/2004CN1495186A Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate
05/11/2004US6734291 Sulfonylation of a di(hydroxymethane)furo(2,3-d)1,3-dioxole derivative with a sulfonyl halide
05/11/2004CA2279428C Compounds and methods for therapeutic intervention in preventing diabetic complications
05/11/2004CA2184411C Process for preparing polymorphs b and c of 1-[2,4-dichloro-.beta.-[(7-chlorobenzo[b]thien-3-yl)methoxy]phenethyl]imidazole mononitrate
05/06/2004WO2004038006A2 Purine nucleosides
05/06/2004WO2004037989A2 Modified nucleotides and methods of labeling nucleic acids
05/06/2004WO2004037842A1 Novel synthetic nucleic acids whose sugar moieties have s-configuration
05/06/2004US20040087555 Phosphohalohydrins, process for the production thereof and use thereof
05/06/2004US20040087541 Crystalline and amorphous forms of beta-L-2'-deoxythymidine
05/06/2004US20040087540 Combinatorial library synthesis and pharmaceutically active compounds produced thereby
05/06/2004US20040087517 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
05/06/2004US20040087482 Microparticle-drug conjugates for biological targeting
05/06/2004US20040086914 Binding using ligase
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 201